| Database ID | Agent | Target | Cancer Type | Detail |
| DB00436 | gefitinib | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00437 | gefitinib | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00438 | gefitinib | Epidermal growth factor receptor | esophageal cancer | view |
| DB00439 | gefitinib | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00440 | gefitinib | Epidermal growth factor receptor | esophageal cancer | view |
| DB00441 | trastuzumab | Receptor proteintyrosine kinase erbB2 | gastric cancer | view |
| DB00442 | trastuzumab | Receptor proteintyrosine kinase erbB2 | esophagusgastroesophageal junction cancer | view |
| DB00443 | trastuzumab | Receptor proteintyrosine kinase erbB2 | esophagusgastroesophageal junction cancer | view |
| DB00444 | trastuzumab | Receptor proteintyrosine kinase erbB2 | esophagusgastroesophageal junction cancer | view |
| DB00445 | trastuzumab | Receptor proteintyrosine kinase erbB2 | esophagusgastroesophageal junction cancer | view |
| DB00446 | trastuzumab | Receptor proteintyrosine kinase erbB2 | esophageal cancer | view |
| DB00447 | trastuzumab | Receptor proteintyrosine kinase erbB2 | esophageal cancer | view |
| DB00448 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | esophagusgastroesophageal junction cancer | view |
| DB00449 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | esophagusgastroesophageal junction cancer | view |
| DB00450 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced solid tumors | view |